$76.7 Million is the total value of ARCH Venture Management, LLC's 5 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RUBY | RUBIUS THERAPEUTICS INC | $24,874,000 | +21.0% | 2,618,351 | 0.0% | 32.42% | +44.1% | |
| SYRS | Sell | SYROS PHARMACEUTICALS INC | $22,898,000 | -42.8% | 3,313,817 | -14.0% | 29.84% | -31.9% |
| IOTS | New | ADESTO TECHNOLOGIES CORP. | $17,438,000 | – | 2,051,511 | +100.0% | 22.73% | – |
| CHMA | CHIASMA INC | $5,936,000 | +0.2% | 1,196,776 | 0.0% | 7.74% | +19.3% | |
| KURA | Sell | KURA ONCOLOGY INC | $5,587,000 | -59.4% | 406,307 | -55.2% | 7.28% | -51.6% |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -716,392 | -100.0% | -12.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RUBIUS THERAPEUTICS, INC. | 12 | Q3 2022 | 65.5% |
| EQRX, INC. | 8 | Q3 2023 | 52.4% |
| ERASCA, INC. | 8 | Q3 2023 | 18.8% |
| VERVE THERAPEUTICS, INC. | 8 | Q3 2023 | 23.3% |
| CHIASMA INC | 8 | Q3 2020 | 25.7% |
| SINGULAR GENOMICS SYSTEMS, INC. | 8 | Q3 2023 | 4.6% |
| KURA ONCOLOGY INC | 7 | Q2 2020 | 27.6% |
| KARUNA THERAPEUTICS, INC. | 6 | Q1 2023 | 52.8% |
| DENALI THERAPEUTICS, INC. | 6 | Q3 2023 | 28.6% |
| SYROS PHARMACEUTICALS INC | 5 | Q3 2020 | 43.8% |
View ARCH Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-27 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View ARCH Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.